Department of Hematopoietic Stem Cell Transplantation, Academy of Military Medical Sciences, Beijing, 100071, China.
Cell and Gene Therapy Center, Academy of Military Medical Sciences, Beijing, 100071, China.
Cell Death Dis. 2018 Jun 7;9(6):677. doi: 10.1038/s41419-018-0721-8.
Hematopoietic stem cells (HSCs) can give rise to all blood cells that are essential to defend against pathogen invasion. The defective capability of HSC self-renewal is linked to many serious diseases, such as anemia. However, the potential mechanism regulating HSC self-renewal has not been thoroughly elucidated to date. In this study, we showed that Zfp90 was highly expressed in HSCs. Zfp90 deficiency in the hematopoietic system caused impaired HSPC pools and led to HSC dysfunction. We showed that Zfp90 deletion inhibited HSC proliferation, while HSC apoptosis was not affected. Regarding the mechanism of this effect on HSC proliferation, we found that Zfp90 interacted with Snf2l, a subunit of the NURF complex, to regulate Hoxa9 expression. Ectopic expression of Hoxa9 rescued the HSC repopulation capacity in Zfp90-deficient mice, which indicates that Hoxa9 is the downstream effector of Zfp90. In summary, our findings identify Zfp90 as a key transcription factor in determining the fate of HSCs.
造血干细胞 (HSCs) 可以产生所有对抵御病原体入侵至关重要的血细胞。HSC 自我更新能力的缺陷与许多严重疾病有关,如贫血。然而,迄今为止,调节 HSC 自我更新的潜在机制尚未得到彻底阐明。在这项研究中,我们表明 Zfp90 在 HSCs 中高度表达。造血系统中 Zfp90 的缺失导致 HSPC 池受损,导致 HSC 功能障碍。我们表明 Zfp90 缺失抑制了 HSC 的增殖,而 HSC 凋亡不受影响。关于这种对 HSC 增殖的影响的机制,我们发现 Zfp90 与 NURF 复合物的一个亚基 Snf2l 相互作用,以调节 Hoxa9 的表达。Hoxa9 的异位表达挽救了 Zfp90 缺陷小鼠的 HSC 再群体能力,这表明 Hoxa9 是 Zfp90 的下游效应物。总之,我们的发现确定 Zfp90 是决定 HSCs 命运的关键转录因子。